An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1
NCT01508130
·
clinicaltrials.gov ↗
COMPLETED
Status
672
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis C, Chronic
Sponsor
Hoffmann-La Roche